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ABSTRACT 
 
 
 
 
The skeletal muscle of obese individuals exhibits a depressed ability to 
metabolize fats.  Exercise training is thought to rescue this dampened ability to 
metabolize fats; mediated by a coordinated increase in the expression of a network of 
genes that regulate metabolism and fuel utilization.  The purpose of this study is to 
determine the exercise-induced regulation of metabolically important genes in lean and 
obese individuals.  Muscle biopsies (one pre-exercise/baseline and one immediately post-
exercise) were obtained from 4 lean (BF% 24.4 ± 5.5; 23.5 yrs ± 1.9) and 13 obese (BF% 
39.7 ± 2.4; 26.1 yrs ± 2.3), age-matched, relatively young subjects, free from overt 
disease, non-smokers, and not taking medications known to alter metabolism.  RNA was 
isolated, quantified, reverse transcribed into cDNA, and evaluated using RT-PCR.  The 
pre-exercise mRNA content of pyruvate dehydrogenase kinase 4 (PDK4) was 
significantly higher in the obese compared to the lean (P=0.04) and the mRNA content of 
peroxisome proliferator-activated receptor alpha (PPARα) was significantly lower 
(P=0.03).  There were no differences in the mRNA content post-exercise.  This suggests 
exercise tends to improve the expression of important metabolic genes in the skeletal 
muscle of the obese. 
Keywords: skeletal muscle, metabolism, exercise, PPARs, PDK4, obese 
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
Obesity: Definition and Prevalence 
In the United States, approximately 35 percent of adults and 17 percent of 
children are considered obese—defined as a body mass index (BMI) greater than 30 
kg/m2 (Ogden, Carroll, Kit, & Flegal, 2014; Smith & Smith, 2016).  Obesity is referred to 
as an imbalance of caloric intake and outflow thought to be the result of a combination of 
environmental, economic, genetic, and individual factors (Smith & Smith, 2016).  As a 
result, research interests have focused on interventions, such as change in diet or physical 
activity, to alter these factors across a population (Flegal KM, Carroll MD, Ogden CL, & 
Johnson CL, 2002).   
In a clinical environment, obesity denotes excess adiposity rather than excess 
weight (Krebs, Jacobson, & American Academy of Pediatrics Committee on Nutrition, 
2003).  Visceral adipose tissue is known to be strongly correlated with increased risk of 
cardiovascular disease (Bouchi et al., 2016; Fox et al., 2007).  However, body 
composition is predominantly defined by BMI, which utilizes body weight (usually in 
kilograms) and height (usually in meters) to quantify an individual’s body composition 
and place them into categories of obese and lean based on age and sex (Etchison et al., 
2011).  BMI only takes into consideration relative body weight and does not consider 
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overall body composition such as body fat or muscle mass (Etchison et al., 2011).  
Therefore, a more accurate method of defining body composition is by assessing body fat 
percentage.  Using dual energy X-ray absorptiometry (DXA), body composition is 
determined by measuring an individual’s fat distribution based on density as well as 
overall and regional body fat estimates (Pierce, 2014; Yang & Chang, 2016). 
Obesity and Metabolic Health 
 Obesity tends to be strongly correlated to the development of insulin resistance, 
metabolic syndrome, type 2 diabetes mellitus, and hypertension (Flegal KM et al., 2002).  
Individuals who are severely obese tend to show altered fatty acid oxidation (FAO) levels 
during fasting and decreased metabolic flexibility in response to insulin in skeletal 
muscle tissue (Chomentowski, Coen, Radiková, Goodpaster, & Toledo, 2011).  
Metabolic flexibility is a term used to refer to an organism’s ability to alter energy 
oxidation to energy availability (Galgani, Moro, & Ravussin, 2008).  More specifically it 
refers to a switch from increased lipid oxidation and high uptake of fatty acids during 
fasting to decreased lipid oxidation and high uptake of glucose in the presence of insulin 
(Kelley & Mandarino, 2000).  Obese individuals with altered metabolic flexibility also 
tend to have increased insulin resistance, although the physiology behind this correlation 
is unclear (Chomentowski et al., 2011).   
 The mitochondria serves as the source of oxidative energy in eukaryotic cells 
(Heilbronn, Gan, Turner, Campbell, & Chisholm, 2007).  The numerous mitochondria in 
human skeletal muscle allow for ample fatty acid oxidation (Chomentowski et al., 2011).  
However, the skeletal muscle of obese individuals tends to demonstrate a diminished 
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mitochondrial capacity (Chomentowski et al., 2011).  In order to understand this 
diminished capacity, research is concentrating on mitochondrial biogenesis (Heilbronn et 
al., 2007).  Mitochondrial biogenesis, which is the process of developing new 
mitochondria in the cells, is mediated by both nuclear and mitochondrial encoded 
genomes (Heilbronn et al., 2007).  The genomes operate in coordination with one another 
to produce numerous proteins involved in the uptake, transport, and oxidation of fatty 
acids not only during rest, but also during muscular activity (Civitarese, Hesselink, 
Russell, Ravussin, & Schrauwen, 2005). 
Exercise and Metabolic Health 
 Research has shown the positive effects exercise has on the entire human body in 
terms of metabolism and energy expenditure (Catoire et al., 2012).  Exercise has been 
shown to reduce cardiovascular disease, type 2 diabetes mellitus, and metabolic 
syndrome (Gaesser, 2007; Kodama et al., 2009; LaMonte, Blair, & Church, 2005).  In the 
skeletal muscle, specifically, exercise increases cellular demands for oxygen, ATP, 
glucose, and fatty acids (Catoire et al., 2012).  This is accompanied by changes in 
enzymatic activity and an increased capacity for FAO as a result of changes in gene 
expression (Catoire et al., 2012; Tunstall et al., 2002).  Aerobic exercise training is 
known to alter expression of mRNA coding for important metabolic proteins and increase 
mitochondrial enzyme activity as well as increase expression of nuclear-encoded genes 
responsible for regulation of mitochondrial transcription in lean individuals (Egan, 
O’Connor, Zierath, & O’Gorman, 2013; Heilbronn et al., 2007).  Genes demonstrating 
increased expression include peroxisome proliferator-activated receptor gamma 
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coactivator-1 alpha (PGC-1α) and mitochondrial transcription factor A (TFAM) 
(Heilbronn et al., 2007).   
However, the overall molecular mechanisms are complex and much is still 
unknown in regards to the transcription and expression of many of the genes encoding for 
proteins involved in increased FAO post-exercise training (Civitarese et al., 2005; 
Tunstall et al., 2002).  The specific effects of exercise training in obese individuals are 
still under investigation.  Researchers are working to determine the extent to which 
exercise can reverse metabolic inflexibility and insulin resistance in the skeletal muscle 
of these obese individuals (Heilbronn et al., 2007). 
Critical Metabolic Genes 
 As mentioned above, PGC-1α is one of the critical genes involved in 
mitochondrial activity (Heilbronn et al., 2007).  This gene is expressed in a variety of 
human tissue types including brown adipose tissue and skeletal muscle, both of which are 
high in mitochondrial density (J. Lin et al., 2002).  Multiple studies have found PGC-1α 
to play a role in conditions such as obesity, diabetes mellitus, neuropathy, and 
cardiomyopathy (J. D. Lin, Handschin, & Spiegelman, 2005). 
Specifically, PGC-1α is a transcriptional coactivator vital to the coordination of 
mitochondria biogenesis (Little, Safdar, Cermak, Tarnopolsky, & Gibala, 2010).  
Research has shown that exercise tends to cause a temporary increase in both PGC-1α 
transcription and mRNA expression in human skeletal muscle up to two hours post-
exercise (Henriette Pilegaard, Saltin, & Neufer, 2003).  Studies have demonstrated that 
activation of PGC-1α appears to facilitate the initial increase in mitochondrial production 
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in response to exercise, while an increase in PGC-1α protein production aids in 
sustaining the production process (Wright et al., 2007).  PGC-1α works by interacting 
with transcription factors bound to the promoter regions of target genes rather than 
binding DNA directly (Henriette Pilegaard et al., 2003).  Once activated in the cytosol of 
the cell, PGC-1α moves to the nuclear membrane where it can interact with nuclear 
respiratory factors, estrogen-related receptor alpha, and myocyte enhancer factor 2 (J. D. 
Lin et al., 2005; Little et al., 2010). 
 The induction of nuclear respiratory factor 1 (NRF-1) gene expression by PGC-1α 
is believed to play a role in activation of mitochondrial biogenesis and cellular respiration 
(Ventura-Clapier, Garnier, & Veksler, 2008).  NRF-1 protein functions primarily as a 
transcription regulator mediating nuclear and mitochondrial interactions by binding 
directly to mitochondrial DNA (mtDNA) (Baar, 2004; Scarpulla, 2002).  A study 
conducted by Patti et al. (2003) demonstrated a correlation between decreased expression 
of NRF-1-dependent genes and type 2 diabetes mellitus associated insulin resistance.  
Figure 1: PGC-1α transcriptional coactivation.  This figure illustrates the interactions of the proteins that result 
from transcription of the genes of interest.  These proteins coactivate mitochondrial DNA transcription. 
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This has created interest in further exploration of the gene’s explicit function.  In rat 
skeletal muscle, NRF-1 mRNA expression was shown to increase following an acute bout 
of exercise (Murakami, Shimomura, Yoshimura, Sokabe, & Fujitsuka, 1998).  Combined 
with the knowledge that exercise training increases the respiratory capacity of human 
skeletal muscle, these findings make further investigation of NRF-1 expression 
advantageous (Baar, 2004).   
 Another downstream target of PGC-1α is mitochondrial transcription factor A 
(TFAM).  The gene is encoded in the nucleus and the resultant protein is transported to 
the mitochondria to carry out its function (Gordon, Rungi, Inagaki, & Hood, 2001).  This 
protein binds to mtDNA and plays a role in its protection and stabilization (Ichiseki et al., 
2015).  TFAM binds to enhancers along the mtDNA strand that are upstream of promoter 
sites (Kelly & Scarpulla, 2004).  Expression of TFAM is regulated by PGC-1α via NRF-1 
and NRF-2 (Finck & Kelly, 2006).  In one study conducted by Short et al. (2003), 
abundance of mRNA encoding PGC-1α, NRF-1, and TFAM was shown to increase in 
response to exercise by 55, 15, and 85%, respectively, indicating these genes are 
prominent regulators of FAO in response to exercise training. 
 Two other peroxisome proliferator-activated receptors, PPARα and PPARδ, also 
play a role in FAO (Luquet et al., 2004).  PPARs are activated by lipid ligands such as 
prostaglandins and eicosanoids (Vega, Huss, & Kelly, 2000; Wagner & Wagner, 2010).  
Once activated, PPARα binds with PGC-1α to regulate transcription of enzymes involved 
in both FAO and the citric acid cycle including acyl coenzyme A (acyl-CoA) 
dehydrogenase (Baar, 2004).  PPARα is found in high levels in tissues with great 
  7 
oxidative energy demands such as muscle and brown adipose tissues while PPARδ is 
expressed abundantly in the skeletal muscle (Manio, Inoue, Fujitani, Matsumura, & 
Fushiki, 2016; Vega et al., 2000).  Less is known about the function of PPARδ, also 
known as PPARβ, which is a ubiquitously expressed protein (Gilde et al., 2003).  
Researchers have demonstrated a positive correlation between PPARδ expression and 
increased FAO along with glucose uptake leading many to believe it could play a role in 
the management of metabolic disorders (Manio et al., 2016). 
 Another downstream target of PGC-1α is pyruvate dehydrogenase kinase 4 
(PDK4) (Wende, Huss, Schaeffer, Giguère, & Kelly, 2005).  PDK4 is activated when 
PGC-1α binds estrogen-related receptor (ERRα) (Wende et al., 2005).  PDK4 is a 
mitochondrial protein that upregulates FAO by inhibiting the pyruvate dehydrogenase 
complex which increases glucose oxidation (Leem & Lee, 2016).  In a study conducted 
by Pilegaard, Ordway, Saltin, & Neufer (2000), transcription of the PDK4 gene was 
shown to increase in response to exercise demonstrating a shift from glycolysis to FAO 
following exercise training.  This information makes this a gene of interest in further 
understanding metabolic flexibility in obese individuals.  
 In summary, our research has demonstrated that obesity is a growing health 
concern that tends to be correlated to the development of insulin resistance, metabolic 
syndrome, type 2 diabetes mellitus, and hypertension (Flegal KM et al., 2002).  Obese 
individuals tend to show decreased fatty acid oxidation (FAO) during fasting and 
decreased metabolic flexibility in skeletal muscle tissue (Chomentowski et al., 2011).  
However, research has shown the positive effects exercise has on metabolism and energy 
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expenditure, specifically the effects of aerobic exercise training on mRNA expression and 
increased mitochondrial enzyme activity as well as increased expression of nuclear-
encoded genes responsible for regulation of mitochondrial transcription in lean 
individuals (Catoire et al., 2012; Egan et al., 2013; Heilbronn et al., 2007).  However, 
much is still unknown about the overall, complex mechanisms in regards to the 
transcription and expression of many of the genes encoding for proteins involved in 
increased FAO post-exercise training (Civitarese et al., 2005; Tunstall et al., 2002).  The 
purpose of the present study is to determine if an acute bout of moderate-intensity 
exercise could favorably impact the expression of metabolically important genes in 
skeletal muscle from obese individuals.
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CHAPTER 2 
 
 
METHODS 
 
 
 This study involved the processing of samples previously collected at East 
Caroline University (ECU) following approval by the ECU University and Medical 
Center Institutional Review Board.  Briefly, lean and obese subjects were briefed on all 
study procedures and signed an informed consent prior to participation.  Subjects 
underwent a general health screening (BMI assessment, resting blood pressure and heart 
rate, etc.) and completed a brief medical history questionnaire.  Biological specimens 
were collected at East Carolina University and skeletal muscle samples were processed at 
Western Kentucky University (WKU) as part of this thesis project, upon receiving 
approval from the WKU Biosafety Committee.
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Figure 2: Study Workflow.  This figure illustrates the overall methodology used to conduct the experiment. 
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Subjects 
Subject demographic and physical characteristics according to categorization by 
BMI are provided in Table 1.  Subjects included 8 lean (BMI 23.1 kg/m2 ± 0.7; 23.8 yrs ± 
1.3) and 9 obese (34.2 kg/m2 ± 1.1; 27.0 yrs ± 3.2) adult humans.  According to Pierce et 
al. (2014), subjects were excluded if they did not fit within preferred BMI categories or 
exercised more than 3 days per week.  Participants included both men and women, who 
were age-matched, relatively young, non-smokers that were not taking any medication 
known to alter their metabolism or pregnant (Pierce, 2014). 
Participants were also categorized according to body fat percentage (BF%) using 
DXA values.  When subjects were categorized as lean versus obese using BF%, 4 were 
classified as lean (BF% 24.4 ± 5.5; 23.5 yrs ± 1.9) and 13 were classified as obese (BF% 
39.7 ± 2.4; 26.1 yrs ± 2.3).  Participant demographics and anthropometric data are 
presented in Table 2 based on categorization by BF%.   
Design 
Briefly, subjects had height measured and weight assessed along with a dual-
energy X-ray absorptiometry (DXA) scan (Prodigy, GE Lunar Corp., Madison, WI) prior 
to the pre-exercise muscle biopsy (Pierce, 2014).  Following the pre-exercise muscle 
biopsy, participants wore a heart rate monitor and exercised at 60% of their heart rate 
reserve (HRR), which approximated 60% of their VO2 max, for 60 minutes on a Monark 
Ergomedic 828E cycle ergometer (See Figure 2) (Monark Exercise, AB, Sweden) 
(Pierce, 2014).  Resting serum levels of glucose and insulin were analyzed for basic 
blood chemistries (Pierce, 2014). 
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Muscle Biopsies 
Approximately 100-150mg of skeletal muscle was obtained from the vastus 
lateralis of subjects by a percutaneous muscle biopsy (See Figure 2).  A 30-45mg sample 
was immediately frozen in liquid nitrogen and stored at -80°C.  An additional 30-45mg 
sample was minced in RNAlater and also stored at -80°C.  Two muscle biopsies were 
performed on each subject: 1) pre-exercise/baseline and 2) immediately post-exercise.   
RNA Isolation and Analysis 
 RNA was isolated for muscle samples using TRIzol® Reagent according to the 
manufacturer’s protocol.  Quantification of RNA samples was first determined using a 
NanoDrop Spectrophotometer.  2μL of each sample was run in duplicate and a mean 
value was calculated for concentration in ng/μL.  The RNA samples were then quantified 
again and also qualified using the Agilent 2100 Bioanalyzer and RNA 6000 Nano Assay 
Kit (See Figure 2).  The RNA Nano Chip was loaded with 1μL of each sample in 
duplicate along with 5μL RNA Nano Marker.  In addition, each chip contained two wells 
of 9μL RNA Nano Gel-Dye Mix and 1μL RNA ladder.  A mean concentration value was 
calculated for concentration in ng/μL.  RNA quality was measured using a mean RNA 
Integrity Number (RIN). 
RNA samples were reverse transcribed into cDNA using a High Capacity cDNA 
Reverse Transcription Kit (See Figure 2).  2μL of buffer, 0.80μL of dNTP mix (100mM), 
2μL of random primers, 1μL of MultiScribe Reverse Transcriptase, and Nuclease-free 
H2O were added to the RNA samples for the reaction.  After being briefly centrifuged, 
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samples were placed in a thermal cycler under the following conditions: 10 minutes at 
25°C, then 120 minutes at 37°C, then 5 minutes 85°C, and infinite hold at 4°C.  
Real time polymerase chain reaction (RT-PCR) was used to evaluate the RNA 
expression of PGC-1α and its five downstream targets (PPARδ, PPARα, NRF-1, TFAM, 
PDK4).  Optimization of the various genes was completed to determine optimal 
concentrations for amplification to occur.  The cDNA samples were multiplexed using 
the endogenous control B2M.  Samples were run in triplicate using TaqMan® Universal 
PCR Master Mix at a 2X concentration, gene expression assays at 20X concentrations, 
and Nuclease-free H2O.  PCR was run using the following cycle profile: 95°C for 10 
minutes × 1 for denaturation, 95°C for 15 seconds × 40 for annealing, and 60°C for 1 
minute × 1 for extension.  The threshold cycle (Ct value) was recorded for each gene of 
interest for each sample (See Figure 2).   
Statistical Analysis 
 Analysis of data between lean and obese demographics and metabolic gene 
expression was assessed using a T-test for independent samples using SPSS statistical 
software.  Data is reported as mean ± SD and α-level was set a p≤ 0.05.
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CHAPTER 3 
 
 
RESULTS 
 
 
Participant’s Weight Status Classified by BMI 
Subjects were categorized by BMI (lean: 23.1 kg/m2 ± 0.7 versus obese 34.2 
kg/m2 ± 1.1, p<0.01).  Anthropometric data are presented in Table 1.  Difference in age 
was insignificant (p=0.37).  Differences in DXA (p=0.03), insulin levels (p<0.01), and 
HOMA-IR (p<0.01) were all significant while difference in glucose levels (p=0.18) was 
insignificant.  
Table 1: Subject Demographics Based on Body Mass Index (BMI)   
  Lean (n=8) Obese (n=9) p-value 
Male/Female 4/4 6/3 n/a 
Age (years) 23.8 ± 1.3 27.0 ± 3.2 0.37 
BMI (kg/m2) 23.1 ± 0.7 34.2 ± 1.1 *            < 0.01 
DXA (Region % Fat) 30 ± 3.8 41.4 ± 2.8 *               0.03 
Glucose (mg/dL) 84.3 ± 2.3  89.1 ± 2.5 0.18 
Insulin (uIU/mL) 6.8 ± 1.1 15.9 ± 1.4 *            < 0.01 
HOMA-IR  1.4 ± 0.2 3.5 ± 0.4 *            < 0.01 
Values are mean ± SD; *P<0.05 vs Lean group  
Table 1: Basic demographic information and anthropometric data for study participants when categorized by 
BMI. 
Participant’s Weight Status Classified by BF% 
Subjects were also categorized by body fat percentage (BF%) based on DXA-
assessed body composition (lean 24.4 ± 5.5 versus obese 39.7 ± 2.4; p=0.01).  Difference 
is age was insignificant (p=0.56) and there was a good distribution of males and females 
  15 
(lean: 2/2 and obese: 8/5) in each group.  However, the group numbers (lean: n=4 and 
obese: n=13) were not equally distributed.  BMI (p<0.01), Android (p=0.02), A/G ratio 
(p=0.03), fasting insulin (p=0.03), and HOMA-IR (p=0.04) were significantly higher in 
the obese subjects.   
Table 2: Subject Demographics Based on Body Fat Percentage (BF%) 
  Lean (n=4) Obese (n=13) p-value 
Male/Female 2/2 8/5 n/a 
Age (years) 23.5 ± 1.9 26.1 ± 2.3 0.56 
BMI (kg/m2) 22.0 ± 1.1 31.2 ± 1.5 *                   < 0.01 
DXA (Region % Fat) 24.4 ± 5.5 39.6 ± 2.4 *                      0.01 
Android (% Fat) 28.2 ± 5.6 50.7 ± 1.7 *                      0.02 
Gynoid (% Fat) 33.0 ± 7.5 44.0 ± 3.4 0.15 
A/G Ratio 0.9 ± 0.1 1.2 ± 0.1 *                      0.03 
Glucose (mg/dL) 84.5 ± 4.5 87.5 ± 1.9 0.57 
Insulin (uIU/mL) 6.2 ± 1.4 13.3 ± 1.5 *                      0.03 
HOMA-IR 1.3 ± 0.3 2.9 ± 0.4 *                      0.04 
Values are mean ± SD; *P<0.05 vs Lean group  
Table 2: Subject demographics and anthropometric data based on categorization by body fat percentage (BF%).  
HOMA-IR refers to a homeostatic model assessment for insulin resistance determined using glucose and insulin 
values. 
mRNA Analysis 
To investigate potential differences in metabolic gene expression between lean 
and obese individuals, that likely influence resting metabolism, mRNA content was 
compared at baseline.  Differences in baseline (pre-exercise) mRNA content between 
lean and obese participants was assessed in two ways—1) based on BMI weight status 
classification and 2) based on BF% weight status classifications.  There were no 
differences in the mRNA content of the genes of interest when groups were determined 
by BF%, there was a difference in the pre-exercise mRNA content of peroxisome 
proliferator-activated receptor alpha (PPARα), which was significantly lower (p=0.03) in 
the obese compared to the lean (See Table 3 and Figure 3).  Pre-exercise mRNA content 
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of pyruvate dehydrogenase kinase 4 (PDK4) was significantly higher in the obese 
compared to the lean (p=0.04) (See Table 3 and Figure 4).  All other mRNA content for 
the other genes showed no difference pre-exercise.  However, an acute bout of exercise 
resulted in no differences in the expression of these genes (PPARα, PDK4) between lean 
and obese individuals.  There were no significant increases in mRNA content observed 
immediately post-exercise for any of the genes analyzed. 
 
 
 
Figure 3: Pre-exercise PPARα gene expression in lean and obese individuals categorized by BF%.  
Expression was significantly higher in lean individuals as compared to obese individuals.  
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Figure 4: Pre- and post-exercise PDK4 gene expression in lean and obese individuals categorized by 
BF%.  Pre-exercise expression was significantly higher in obese individuals as compared to lean 
individuals.  No significant difference was seen post-exercise. 
 
 
Table 3: Gene Expression Pre- and Post-Exercise   
  Lean (n=4) Obese (n=13) p-value 
Male/Female 2/2 8/5 n/a 
Age (years) 23.5 ± 1.9 26.1 ± 2.3 0.56 
DXA (Region % Fat) 24.4 ± 5.5 39.6 ± 2.4 *                      0.01 
TFAM PreEx 0.21 ± 0.01 0.11 ± 0.03 0.18 
TFAM PostEx 0.11 ± 0.03 0.12 ± 0.03 0.82 
PDK4 PreEx 0.02 ± 0.01 0.07 ± 0.01 *                      0.04 
PDK4 PostEx 0.18 ± 0.09 0.12 ± 0.03 0.41 
PGC-1α PreEx 0.07 ± 0.03 0.09 ± 0.02 0.71 
PGC-1α PostEx 0.11 ± 0.05 0.09 ± 0.03 0.73 
NRF-1 PreEx 0.10 ± 0.03 0.10 ± 0.02 0.95 
NRF-1 PostEx 0.10 ± 0.02 0.14 ± 0.03 0.50 
PPARδ PreEx 0.10 ± 0.02 0.11 ± 0.02 1.00 
PPARδ PostEx 0.08 ± 0.03 0.21 ± 0.08 0.34 
PPARα PreEx 0.15 ± 0.03 0.08 ± 0.01 *                      0.03 
PPARα PostEx 0.14 ± 0.05 0.11 ± 0.02 0.60 
Values are mean ± SD; *P<0.05 vs Lean group  
Table 3: Difference in gene expression based on results from RT-PCR of reverse-transcribed cDNA from RNA 
of subjects’ muscle biopsies.  Significant differences were found in PDK4 expression pre-exercise and in PPARα 
expression pre-exercise. 
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CHAPTER 4 
 
 
DISCUSSION 
 
 
In the current study, exercise-induced differences in metabolic gene expression 
were examined in lean and obese individuals.  The primary findings of this study were 
the following: 1) pre-exercise gene expression of pyruvate dehydrogenase kinase 4 
(PDK4) was higher in obese compared to lean subjects and 2) pre-exercise gene 
expression of peroxisome proliferator-activated receptor alpha (PPARα) was lower in 
obese compared to lean subjects.  These findings were observed when subjects were 
categorized by body fat percentage (BF%).  No differences in metabolic gene expression 
were observed post-exercise.  When subjects were categorized by body mass index 
(BMI), no difference in metabolic gene expression was observed pre- or post-exercise. 
The observed higher levels of gene expression of PDK4 in obese subjects 
corresponded with findings from other studies.  PDK4 is an enzyme known to inhibit the 
pyruvate dehydrogenase complex that stimulates oxidation of glucose for energy use 
(Leem & Lee, 2016).  PDK4 thus inhibits the breakdown of stored glucose.  Lower levels 
of insulin along with increased levels of fatty acids promote PDK4 expression (Huang, 
Wu, Bowker-Kinley, & Harris, 2002).  This has been demonstrated in studies that show 
increased expression of PDK4 in individuals with diabetes or insulin-resistance (Kwon, 
Huang, Unterman, & Harris, 2004; Rosa et al., 2003).  Another study demonstrated 
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upregulation of PDK4 following a high fat diet (Constantin-Teodosiu, Constantin, 
Stephens, Laithwaite, & Greenhaff, 2012).  However, another study in transgenic mice in 
which the PDK4 gene had been deleted showed improved glucose metabolism (Tao, 
Xiong, Harris, White, & Dong, 2013).  In addition, a study conducted by Kwon et al. 
(2004) demonstrated that insulin led to a decreased expression of PDK4 under normal 
physiological conditions allowing for utilization of stored glucose for energy.  These 
studies in addition to the current study lead to the conclusion that the higher level of 
baseline expression of PDK4 in obese individuals is related to insulin resistance.  
Although fasting insulin levels were significantly higher in the obese subjects (13.3 ± 1.5 
μIU/mL vs. 6.2 ± 1.4 μIU/mL; p=0.03), it did not result in decreased PDK4 expression. 
The decreased levels of PPARα gene expression pre-exercise in obese subjects 
from the current study correspond to findings of other studies.  PPARα is expressed most 
abundantly in tissues with high oxidative energy demands due to its role as a co-regulator 
of transcription of enzymes involved in FAO (Baar, 2004; Manio et al., 2016; Vega et al., 
2000).  In a study conducted by Costet et al. (1998), absence of this gene was shown to 
be highly correlated to obesity.  Additionally, studies have been conducted that show 
decreased expression of PPARα to be positively correlated with reduced insulin 
sensitivity, diabetic conditions, and adiposity (Chou et al., 2002; Fu et al., 2003; Guerre-
Millo et al., 2000; Kim et al., 2003).  These findings in addition to the current study seem 
to show a positive correlation between PPARα gene expression and improved metabolic 
health. 
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The insignificant differences observed in all other genes pre- and post-exercise 
could be the result of several factors.  This study was limited by the small sample size 
(n=17) and by the uneven distribution of participants when categorized by BF% (lean: 
n=4; obese: n=13).  Another limit to the study was the time of muscle biopsy collection.  
In order to maintain minimal discomfort for participants, only one biological specimen 
was collected per subject immediately post-exercise.  Collecting multiple muscle biopsies 
at varying post-exercise time intervals would have allowed for a more comprehensive 
examination of metabolic gene expression post-exercise. 
In conclusion, the elevated levels of PDK4 in obese individuals pre-exercise are 
consistent with findings in other studies that show elevated baseline expression with 
higher insulin levels.  The baseline differences (between lean and obese) in PPARα 
expression appear to be consistent with a compromised metabolic function in obese 
individuals that then seems to be abolished with an acute bout of exercise.  These 
findings indicate even a relatively mild, acute exercise stimulus may be helpful in 
improving the metabolic health of obese individuals. 
 
  21 
REFERENCES 
 
 
Baar, K. (2004). Involvement of PPAR gamma co-activator-1, nuclear respiratory factors 
1 and 2, and PPAR alpha in the adaptive response to endurance exercise. The 
Proceedings of the Nutrition Society, 63(2), 269–273. 
http://doi.org/10.1079/PNS2004334 
Bouchi, R., Asakawa, M., Ohara, N., Nakano, Y., Takeuchi, T., Murakami, M., … 
Ogawa, Y. (2016). Indirect measure of visceral adiposity “A Body Shape Index” 
(ABSI) is associated with arterial stiffness in patients with type 2 diabetes. BMJ 
Open Diabetes Research & Care, 4(1). http://doi.org/10.1136/bmjdrc-2015-
000188 
Catoire, M., Mensink, M., Boekschoten, M. V., Hangelbroek, R., Müller, M., Schrauwen, 
P., & Kersten, S. (2012). Pronounced Effects of Acute Endurance Exercise on 
Gene Expression in Resting and Exercising Human Skeletal Muscle. PLoS ONE, 
7(11), 1–10. http://doi.org/10.1371/journal.pone.0051066 
Chomentowski, P., Coen, P. M., Radiková, Z., Goodpaster, B. H., & Toledo, F. G. S. 
(2011). Skeletal Muscle Mitochondria in Insulin Resistance: Differences in 
Intermyofibrillar Versus Subsarcolemmal Subpopulations and Relationship to 
Metabolic Flexibility. The Journal of Clinical Endocrinology and Metabolism, 
96(2), 494–503. http://doi.org/10.1210/jc.2010-0822 
  22 
Chou, C. J., Haluzik, M., Gregory, C., Dietz, K. R., Vinson, C., Gavrilova, O., & 
Reitman, M. L. (2002). WY14,643, a Peroxisome Proliferator-activated Receptor 
α (PPARα) Agonist, Improves Hepatic and Muscle Steatosis and Reverses Insulin 
Resistance in Lipoatrophic A-ZIP/F-1 Mice. Journal of Biological Chemistry, 
277(27), 24484–24489. http://doi.org/10.1074/jbc.M202449200 
Civitarese, A. E., Hesselink, M. K. C., Russell, A. P., Ravussin, E., & Schrauwen, P. 
(2005). Glucose ingestion during exercise blunts exercise-induced gene 
expression of skeletal muscle fat oxidative genes. American Journal of 
Physiology - Endocrinology and Metabolism, 289(6), E1023–E1029. 
http://doi.org/10.1152/ajpendo.00193.2005 
Constantin-Teodosiu, D., Constantin, D., Stephens, F., Laithwaite, D., & Greenhaff, P. L. 
(2012). The Role of FOXO and PPAR Transcription Factors in Diet-Mediated 
Inhibition of PDC Activation and Carbohydrate Oxidation During Exercise in 
Humans and the Role of Pharmacological Activation of PDC in Overriding These 
Changes. Diabetes, 61(5), 1017–1024. http://doi.org/10.2337/db11-0799 
Costet, P., Legendre, C., Moré, J., Edgar, A., Galtier, P., & Pineau, T. (1998). 
Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to 
progressive dyslipidemia with sexually dimorphic obesity and steatosis. The 
Journal of Biological Chemistry, 273(45), 29577–29585. 
 
  23 
Egan, B., O’Connor, P. L., Zierath, J. R., & O’Gorman, D. J. (2013). Time Course 
Analysis Reveals Gene-Specific Transcript and Protein Kinetics of Adaptation to 
Short-Term Aerobic Exercise Training in Human Skeletal Muscle. PLoS ONE, 
8(9), 1–13. http://doi.org/10.1371/journal.pone.0074098 
Etchison, W. C., Bloodgood, E. A., Minton, C. P., Thompson, N. J., Collins, M. A., 
Hunter, S. C., & Dai, H. (2011). Body Mass Index and Percentage of Body Fat as 
Indicators for Obesity in an Adolescent Athletic Population. Sports Health, 3(3), 
249–252. http://doi.org/10.1177/1941738111404655 
Finck, B. N., & Kelly, D. P. (2006). PGC-1 coactivators: inducible regulators of energy 
metabolism in health and disease. Journal of Clinical Investigation, 116(3), 615–
622. http://doi.org/10.1172/JCI27794 
Flegal KM, Carroll MD, Ogden CL, & Johnson CL. (2002). PRevalence and trends in 
obesity among us adults, 1999-2000. JAMA, 288(14), 1723–1727. 
http://doi.org/10.1001/jama.288.14.1723 
Fox, C. S., Massaro, J. M., Hoffmann, U., Pou, K. M., Maurovich-Horvat, P., Liu, C.-Y., 
… O’Donnell, C. J. (2007). Abdominal Visceral and Subcutaneous Adipose 
Tissue Compartments Association With Metabolic Risk Factors in the 
Framingham Heart Study. Circulation, 116(1), 39–48. 
http://doi.org/10.1161/CIRCULATIONAHA.106.675355 
  24 
Fu, J., Gaetani, S., Oveisi, F., Lo Verme, J., Serrano, A., Rodríguez De Fonseca, F., … 
Piomelli, D. (2003). Oleylethanolamide regulates feeding and body weight 
through activation of the nuclear receptor PPAR-alpha. Nature, 425(6953), 90–
93. http://doi.org/10.1038/nature01921 
Gaesser, G. A. (2007). Exercise for prevention and treatment of cardiovascular disease, 
type 2 diabetes, and metabolic syndrome. Current Diabetes Reports, 7(1), 14–19. 
Galgani, J. E., Moro, C., & Ravussin, E. (2008). Metabolic flexibility and insulin 
resistance. American Journal of Physiology - Endocrinology and Metabolism, 
295(5), E1009–E1017. http://doi.org/10.1152/ajpendo.90558.2008 
Gilde, A. J., van der Lee, K. A. J. M., Willemsen, P. H. M., Chinetti, G., van der Leij, F. 
R., van der Vusse, G. J., … van Bilsen, M. (2003). Peroxisome proliferator-
activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, 
modulate the expression of genes involved in cardiac lipid metabolism. 
Circulation Research, 92(5), 518–524. 
http://doi.org/10.1161/01.RES.0000060700.55247.7C 
Gordon, J. W., Rungi, A. A., Inagaki, H., & Hood, D. A. (2001). Selected Contribution: 
Effects of contractile activity on mitochondrial transcription factor A expression 
in skeletal muscle. Journal of Applied Physiology, 90(1), 389–396. 
Guerre-Millo, M., Gervois, P., Raspé, E., Madsen, L., Poulain, P., Derudas, B., … Staels, 
B. (2000). Peroxisome Proliferator-activated Receptor α Activators Improve 
Insulin Sensitivity and Reduce Adiposity. Journal of Biological Chemistry, 
275(22), 16638–16642. http://doi.org/10.1074/jbc.M907421199 
  25 
Heilbronn, L. K., Gan, S. K., Turner, N., Campbell, L. V., & Chisholm, D. J. (2007). 
Markers of Mitochondrial Biogenesis and Metabolism Are Lower in Overweight 
and Obese Insulin-Resistant Subjects. The Journal of Clinical Endocrinology & 
Metabolism, 92(4), 1467–1473. http://doi.org/10.1210/jc.2006-2210 
Huang, B., Wu, P., Bowker-Kinley, M. M., & Harris, R. A. (2002). Regulation of 
Pyruvate Dehydrogenase Kinase Expression by Peroxisome Proliferator–
Activated Receptor-α Ligands, Glucocorticoids, and Insulin. Diabetes, 51(2), 
276–283. http://doi.org/10.2337/diabetes.51.2.276 
Ichiseki, T., Ueda, S., Ueda, Y., Kaneuji, A., Kawahara, N., & Matsumoto, T. (2015). 
Age-related changes of mitochondrial transcription factor a expression in rotator 
cuff degeneration. American Journal of Translational Research, 7(10), 2099–
2104. 
Kelley, D. E., & Mandarino, L. J. (2000). Fuel selection in human skeletal muscle in 
insulin resistance: a reexamination. Diabetes, 49(5), 677–683. 
http://doi.org/10.2337/diabetes.49.5.677 
Kelly, D. P., & Scarpulla, R. C. (2004). Transcriptional regulatory circuits controlling 
mitochondrial biogenesis and function. Genes & Development, 18(4), 357–368. 
http://doi.org/10.1101/gad.1177604 
Kim, H., Haluzik, M., Asghar, Z., Yau, D., Joseph, J. W., Fernandez, A. M., … LeRoith, 
D. (2003). Peroxisome Proliferator–Activated Receptor-α Agonist Treatment in a 
Transgenic Model of Type 2 Diabetes Reverses the Lipotoxic State and Improves 
  26 
Glucose Homeostasis. Diabetes, 52(7), 1770–1778. 
http://doi.org/10.2337/diabetes.52.7.1770 
Kodama, S., Saito, K., Tanaka, S., Maki, M., Yachi, Y., Asumi, M., … Sone, H. (2009). 
Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and 
cardiovascular events in healthy men and women: a meta-analysis. JAMA, 
301(19), 2024–2035. http://doi.org/10.1001/jama.2009.681 
Krebs, N. F., Jacobson, M. S., & American Academy of Pediatrics Committee on 
Nutrition. (2003). Prevention of pediatric overweight and obesity. Pediatrics, 
112(2), 424–430. 
Kwon, H.-S., Huang, B., Unterman, T. G., & Harris, R. A. (2004). Protein Kinase B-α 
Inhibits Human Pyruvate Dehydrogenase Kinase-4 Gene Induction by 
Dexamethasone Through Inactivation of FOXO Transcription Factors. Diabetes, 
53(4), 899–910. http://doi.org/10.2337/diabetes.53.4.899 
LaMonte, M. J., Blair, S. N., & Church, T. S. (2005). Physical activity and diabetes 
prevention. Journal of Applied Physiology (Bethesda, Md.: 1985), 99(3), 1205–
1213. http://doi.org/10.1152/japplphysiol.00193.2005 
Leem, J., & Lee, I. K. (2016). Mechanisms of Vascular Calcification: The Pivotal Role of 
Pyruvate Dehydrogenase Kinase 4. Endocrinology and Metabolism (Seoul, 
Korea), 31(1), 52–61. http://doi.org/10.3803/EnM.2016.31.1.52 
Lin, J. D., Handschin, C., & Spiegelman, B. M. (2005). Metabolic control through the 
PGC-1 family of transcription coactivators. Cell Metabolism, 1(6), 361–370. 
http://doi.org/10.1016/j.cmet.2005.05.004 
  27 
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., … Spiegelman, B. M. 
(2002). Transcriptional co-activator PGC-1 alpha drives the formation of slow-
twitch muscle fibres. Nature, 418(6899), 797–801. 
http://doi.org/10.1038/nature00904 
Little, J. P., Safdar, A., Cermak, N., Tarnopolsky, M. A., & Gibala, M. J. (2010). Acute 
endurance exercise increases the nuclear abundance of PGC-1alpha in trained 
human skeletal muscle. American Journal of Physiology. Regulatory, Integrative 
and Comparative Physiology, 298(4), R912–917. 
http://doi.org/10.1152/ajpregu.00409.2009 
Luquet, S., Lopez-Soriano, J., Holst, D., Gaudel, C., Jehl-Pietri, C., Fredenrich, A., & 
Grimaldi, P. A. (2004). Roles of peroxisome proliferator-activated receptor delta 
(PPARdelta) in the control of fatty acid catabolism. A new target for the treatment 
of metabolic syndrome. Biochimie, 86(11), 833–837. 
http://doi.org/10.1016/j.biochi.2004.09.024 
Manio, M. C. C., Inoue, K., Fujitani, M., Matsumura, S., & Fushiki, T. (2016). Combined 
pharmacological activation of AMPK and PPARδ potentiates the effects of 
exercise in trained mice. Physiological Reports, 4(5), e12625. 
http://doi.org/10.14814/phy2.12625 
  28 
Murakami, T., Shimomura, Y., Yoshimura, A., Sokabe, M., & Fujitsuka, N. (1998). 
Induction of nuclear respiratory factor-1 expression by an acute bout of exercise 
in rat muscle. Biochimica et Biophysica Acta (BBA) - General Subjects, 1381(1), 
113–122. http://doi.org/10.1016/S0304-4165(98)00018-X 
Ogden, C. L., Carroll, M. D., Kit, B. K., & Flegal, K. M. (2014). Prevalence of 
Childhood and Adult Obesity in the United States, 2011-2012. JAMA: Journal of 
the American Medical Association, 311(8), 806. 
http://doi.org/10.1001/jama.2014.732 
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., … Mandarino, 
L. J. (2003). Coordinated reduction of genes of oxidative metabolism in humans 
with insulin resistance and diabetes: Potential role of PGC1 and NRF1. 
Proceedings of the National Academy of Sciences of the United States of America, 
100(14), 8466–8471. http://doi.org/10.1073/pnas.1032913100 
Pierce, J. R. (2014). IL-15 : A NOVEL REGULATOR OF LIPOLYSIS IN HUMANS? 
Retrieved from http://thescholarship.ecu.edu/handle/10342/4438 
Pilegaard, H., Ordway, G. A., Saltin, B., & Neufer, P. D. (2000). Transcriptional 
regulation of gene expression in human skeletal muscle during recovery from 
exercise. American Journal of Physiology. Endocrinology and Metabolism, 
279(4), E806–814. 
Pilegaard, H., Saltin, B., & Neufer, P. D. (2003). Exercise induces transient 
transcriptional activation of the PGC-1alpha gene in human skeletal muscle. The 
Journal of Physiology, 546(Pt 3), 851–858. 
  29 
Rosa, G., Di Rocco, P., Manco, M., Greco, A. V., Castagneto, M., Vidal, H., & 
Mingrone, G. (2003). Reduced PDK4 expression associates with increased insulin 
sensitivity in postobese patients. Obesity Research, 11(2), 176–182. 
http://doi.org/10.1038/oby.2003.28 
Scarpulla, R. C. (2002). Nuclear activators and coactivators in mammalian mitochondrial 
biogenesis. Biochimica Et Biophysica Acta, 1576(1-2), 1–14. 
Short, K. R., Vittone, J. L., Bigelow, M. L., Proctor, D. N., Rizza, R. A., Coenen-
Schimke, J. M., & Nair, K. S. (2003). Impact of Aerobic Exercise Training on 
Age-Related Changes in Insulin Sensitivity and Muscle Oxidative Capacity. 
Diabetes, 52(8), 1888–1896. http://doi.org/10.2337/diabetes.52.8.1888 
Smith, K. B., & Smith, M. S. (2016). Obesity Statistics. Primary Care, 43(1), 121–135. 
http://doi.org/10.1016/j.pop.2015.10.001 
Tao, R., Xiong, X., Harris, R. A., White, M. F., & Dong, X. C. (2013). Genetic 
Inactivation of Pyruvate Dehydrogenase Kinases Improves Hepatic Insulin 
Resistance Induced Diabetes. PLoS ONE, 8(8). 
http://doi.org/10.1371/journal.pone.0071997 
  30 
Tunstall, R. J., Mehan, K. A., Wadley, G. D., Collier, G. R., Bonen, A., Hargreaves, M., 
& Cameron-Smith, D. (2002). Exercise training increases lipid metabolism gene 
expression in human skeletal muscle. American Journal of Physiology. 
Endocrinology and Metabolism, 283(1), E66–72. 
http://doi.org/10.1152/ajpendo.00475.2001 
Vega, R. B., Huss, J. M., & Kelly, D. P. (2000). The coactivator PGC-1 cooperates with 
peroxisome proliferator-activated receptor alpha in transcriptional control of 
nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Molecular 
and Cellular Biology, 20(5), 1868–1876. 
Ventura-Clapier, R., Garnier, A., & Veksler, V. (2008). Transcriptional control of 
mitochondrial biogenesis: the central role of PGC-1α. Cardiovascular Research, 
79(2), 208–217. http://doi.org/10.1093/cvr/cvn098 
Wagner, K.-D., & Wagner, N. (2010). Peroxisome proliferator-activated receptor 
beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple 
cellular functions. Pharmacology & Therapeutics, 125(3), 423–435. 
http://doi.org/10.1016/j.pharmthera.2009.12.001 
Wende, A. R., Huss, J. M., Schaeffer, P. J., Giguère, V., & Kelly, D. P. (2005). PGC-1α 
Coactivates PDK4 Gene Expression via the Orphan Nuclear Receptor ERRα: a 
Mechanism for Transcriptional Control of Muscle Glucose Metabolism. 
Molecular and Cellular Biology, 25(24), 10684–10694. 
http://doi.org/10.1128/MCB.25.24.10684-10694.2005 
  31 
Wright, D. C., Han, D.-H., Garcia-Roves, P. M., Geiger, P. C., Jones, T. E., & Holloszy, 
J. O. (2007). Exercise-induced Mitochondrial Biogenesis Begins before the 
Increase in Muscle PGC-1α Expression. Journal of Biological Chemistry, 282(1), 
194–199. http://doi.org/10.1074/jbc.M606116200 
Yang, H. R., & Chang, E. J. (2016). Insulin resistance, body composition, and fat 
distribution in obese children with nonalcoholic fatty liver disease. Asia Pacific 
Journal of Clinical Nutrition, 25(1), 126–133. 
 
